WST
West Pharmaceutical·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 6
Bearish signal 0
Dividend Aristocrat
Consensus Rating "Strong Buy"
Ample Liquidity
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About WST
West Pharmaceutical Services, Inc.
A global leader in innovative solutions for injectable drug administration
Healthcare Equipment and Supplies
07/27/1923
10/27/1980
New York Stock Exchange
10,600
12-31
Common stock
530 Herman O. West Drive, Exton, PA 19341-1147
--
West Pharmaceutical Services, Inc., was incorporated under the laws of Pennsylvania on July 27, 1923. The company is a leading global manufacturer of technologically advanced, high-quality, integrated sealing and delivery systems for injectable pharmaceuticals and healthcare products. The company's products include a variety of primary packaging, containment solutions, refactoring and transfer systems, drug delivery systems, as well as contract manufacturing, analytical laboratory services and integrated solutions.
Earnings Call
Q1/2025
Estimate EPS1.23
Actual EPS1.45
Estimate Revenue686.29M
Actual Revenue698.00M
Contradictions Unveiled: Tariffs, HVP Growth, and Demand Dynamics in Recent Earnings Call
May 07,2025 07:24
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS1.51
Actual EPS1.84
Estimate Revenue726.18M
Actual Revenue766.50M
West Pharmaceutical Services Q2 2025: Navigating Contradictions in Growth, Automation, and Revenue Dynamics
Jul 24,2025 02:08
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
WST has released its 2025 Q3 earnings. EPS was reported at 1.96, versus the expected 1.69, beating expectations. The chart below visualizes how WST has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
WST has released its 2025 Q3 earnings report, with revenue of 804.60M, reflecting a YoY change of 7.73%, and net profit of 140.00M, showing a YoY change of 2.94%. The Sankey diagram below clearly presents WST's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
